Although TLR8 is a marker related to the activation of innate immunity while inhibiting the regulatory effect of T cells in other gynecological cancers [47], in cervical cancer, it has been observed in other studies that this receptor influences the antitumor immune response and may be an interesting therapeutic target in cervical cancer [37]. Here, TLR8 is linked to cervical carcinoma.